𝔖 Bobbio Scriptorium

✦ LIBER ✦

Higher doses of α-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma

✍ Scribed by L. Trandafir; P. Ruffié; C. Borel; I. Monnet; P. Soulié; D. Adams; E. Cvitkovic; J.P. Armand

Book ID: 117663982
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 362 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)00263-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined regimen of cisplatin, doxorubic

Combined regimen of cisplatin, doxorubicin, and α-2b interferon in the treatment of advanced malignant pleural mesothelioma : A Phase II multicenter trial of the Italian group on rare tumors (GITR) and the italian lung cancer task force (FONICAP)

✍ Héctor Soto Parra; Lucia Tixi; Fiorenza Latteri; Sergio Bretti; Marco Alloisio; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

Combined regimen of cisplatin (CDDP), ad

Combined regimen of cisplatin (CDDP), adriamycin (ADM) and a-2b interferon (IFN) in the treatment of advanced malignant pleural mesothelioma (MPM): A phase II multicenter trial of the Italian Group on Rare Tumors and Italian Lung Cancer Task Force (FONICAP)

✍ Santoro, A; Tixi, L; Soto Parra, H.J; Ardizzoni, A; Latteri, F; Bretti, S; Gravi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB